Development and evaluation of a multidisciplinary medication management program in long-term care facility residents

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008157

Enrollment

1672

Registered

2023-02-03

Start date

2023-01-17

Completion date

Unknown

Last updated

2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : Conducting a patient-centered multilateral review of the appropriateness of all medications taken by residents of long-term care facilities in cooperation with doctors, pharmacists, and nurse

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) 65 years of age or older; (2) A person who meets under one or more of the following - New residents who have been admitted to long-term care facilities within 4 to 6 weeks - Patients who have been discharged within 1 month prior to the date of visit - Those who have experienced a fall or fracture within 3 months prior to the date of visit - Long-term care level 1 - Those who take more than 10 multi-drugs, excluding pRNs when needed - Those who take medicines of concern for misuse (e.g., narcotic painkillers, inhalers, etc.) - Those who take drugs with a narrow margin of safety or high-risk drugs (e.g., narcotic analgesics, antiepileptics, digoxin, theophylline, immunosuppressants, anticancer drugs, anticoagulants, insulin, benzodiazepines, etc.) - Those who have experienced suspected drug side effects before or during admission to a long-term care facility - Requesters for doctors, nurses, pharmacists, and caregivers

Exclusion criteria

Exclusion criteria: (1) Those who are quarantined due to an infectious disease (2) In case of receiving regular drug prescription at a tertiary general hospital (long-term prescription for more than 90 days, the risk of potentially inappropriate drug occurrence is relatively low) (3) If the life expectancy is predicted to be less than 6 months by a doctor or nurse (terminal cancer, etc.)

Design outcomes

Primary

Measure	Time frame
Adverse drug reactions, number/number/rate of potentially inappropriate drugs, number/rate of users of two or more CNS contractiles, delirium, number of emergency room visits, hospitalizations, and falls	—

Secondary

Measure	Time frame
Number of medications taken, number/rate of polypharmacy users	—

Countries

Korea, Republic of

Contacts

Public ContactHye Jun Lee

Chung-Ang Univerisity Hospital

infiniteme@cauhs.or.kr+82-2-1800-1114

Outcome results